- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
CHMP Market Currents
more »
-
January 20 Cell Therapeutics (CTIC) finishes the day up nearly 15% after saying earlier this morning that it's expecting the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) to release its opinion on the company's Marketing Authorization Application for Pixuvri in mid-February.
Comment![Healthcare, Global & FX, On the Move]
CHMP in Focus
more »
CHMP Related Articles
more »
CHMP News
more »
Currently, there are no news on CHMP.
CHMP Press Releases and Filings
more »
-
PR Newswire (Mar 12, 2012)
CHMP Latest Transcript
more »
Currently, there are no transcripts for CHMP.
CHMP Cramer
more »
Currently, there are no Cramer articles on CHMP.
CHMP Instablog posts
more »
CHMP vs. ETF Alternatives
Company Description
Currently, there's no company description for CHMP.